CDC Vaccine Committee Meeting Scheduled for April 15, 2025

The U.S. Department of Health and Human Services today filed a [Docket No. CDC-2025-0017] notice regarding a meeting of the Advisory Committee on Immunization Practices (ACIP), the vaccine advisory committee of the Centers for Disease Control and Prevention (CDC).

The ACIP advises the Director of the CDC on the use of immunizing agents.

As of March 21, 2025, this newly scheduled ACIP meeting will be held on April 15 and April 16, 2025, and will be digitally open to the public.

The agenda will include discussions on chikungunya, COVID-19, cytomegalovirus, Human papillomavirus, influenza, Lyme disease, meningococcal, mpox, pneumococcal, Respiratory Syncytial Virus vaccines for adults, and maternal and pediatric populations.

An update on the current measles outbreak in the U.S. will also be provided.

ACIP recommendation votes are scheduled for meningococcal, chikungunya, and RSV vaccines for adults.

Of note, VIMKUNYA® became the first chikungunya vaccine approved in the U.S. for people aged 12 and older as of March 18, 2025, without an ACIP recommendation. 

A Vaccines for Children vote is also scheduled for meningococcal vaccines.

The agenda for this ACIP meeting is similar to the rescheduled February 2025 session.

To increase trust in the vaccine authorization process, the CDC launched a website in early March 2025 identifying ACIP member conflicts of interest, if any. Revealed on March 7, 2025, people can use this free CDC digital tool to quickly find previous conflicts of interest by ACIP members from 2000 to 2024.